HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 68289566, compound → N-[1-(3-tert-Butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-N-cyclopropyl-3-fluoro-4-oxazol-5-yl-benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 68289566 | HCID 68289566 | — |
| Reactant | 3-Fluoro-4-oxazol-5-yl-benzoic acid | HCID 68290144 | — |
| Product | N-[1-(3-tert-Butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-N-cyclopropyl-3-fluoro-4-oxazol-5-yl-benzamide | HCID 68351901 | — |
Reaction Steps
The title compound is prepared from [1-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-cyclopropyl-amine and 3-fluoro-4-oxazol-5-yl-benzoic acid following a procedure analogous to that described in Example 17. LC (method 1): tR=1.26 min; Mass spectrum (ESI+): m/z=454 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08822471B2 |
| Source dataset | uspto-grants-2014_09 |
| ORD ID | ord-72f6f3b0cba3499c8553271fcf34e465 |
| Source note | uspto-grants-2014_09 |